Recurrence: all 3,523 studies
Page 19 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in EuropeCompletedNCT05123950
- A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLCStatus unknownNCT05118451Not applicable
- Anti-PD-1 Antibody Plus Chidamide and Rituximab Regimen in Relapsed or Refractory DLBCL (PCR)Status unknownNCT05115409Phase 2
- PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesTerminatedNCT05107856Phase 1
- A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic MalignancyActive, not recruitingNCT05104775Phase 1
- Recurrence of Trigeminal Neuralgia in Patient's Undergoing Radiofrequency AblationCompletedNCT05101577
- A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)Status unknownNCT05100303Phase 1/2
- Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis DiagnosisCompletedNCT05095766
- A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationActive, not recruitingNCT05090371Phase 4
- Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin InstillationStatus unknownNCT05084586Not applicable
- Longitudinal Bladder Cancer Study for Tumour RecurrenceActive, not recruitingNCT05080998
- Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaActive, not recruitingNCT05079282Phase 1
- Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal UrethrotomyCompletedNCT05069883Not applicable
- A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)CompletedNCT05068609
- Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid TumorsWithdrawnNCT05060276Phase 1
- Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian CancerStatus unknownNCT05059782Not applicable
- Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric CancerStatus unknownNCT05053295Not applicable
- Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MMStatus unknownNCT05052970Phase 1
- RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid TumorsTerminatedNCT05052255Phase 1/2
- A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's SarcomaCompletedNCT05046314Phase 2
- Empathetic Communication Facilitation Program for Early Initiation of End-of-life DiscussionsCompletedNCT05045040Not applicable
- Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic SyndromeStatus unknownNCT05044169Not applicable
- A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell CarcinomaActive, not recruitingNCT05043922Phase 2
- Long-term Outcome After Pit-pick for Simple Pilonidal Sinus DiseaseCompletedNCT05027607
- Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 StudyCompletedNCT05019989Not applicable
- Effect of Piezoelectric Alveolar Decortication on Post-Orthodontic Lower Incisors Stability: A Randomized Clinical TrialCompletedNCT05014308Not applicable
- A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple MyelomaCompletedNCT05011097Phase 1
- A Study of Ruxolitinib and Duvelisib in People With LymphomaActive, not recruitingNCT05010005Phase 1
- Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer PatientsCompletedNCT05002140Phase 1
- A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)TerminatedNCT05001282Phase 1/2
- Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)CompletedNCT04997902Phase 1/2
- Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)CompletedNCT04996758Phase 2
- Dissecting the Pathways of Therapy Resistance in Early Breast CancerTerminatedNCT04995575
- tDCS to Prevent Relapse in Alcohol Use DisorderCompletedNCT04990375Not applicable
- Study of Lacutamab in Peripheral T-cell LymphomaActive, not recruitingNCT04984837Phase 2
- Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple MyelomaStatus unknownNCT04984434Phase 1
- PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate CancerCompletedNCT04983459
- Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic AdenocarcinomaTerminatedNCT04983407Phase 1/2
- A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionStatus unknownNCT04981665Phase 2
- LaseRF Trial: Radiofrequency Ablation vs. Laser Hemorrhoidoplasty for Hemorrhoidal DiseaseCompletedNCT04981600Not applicable
- Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple MyelomaTerminatedNCT04975399Phase 1
- Efficacy of Estrogen-intrauterine Stent System After Intrauterine AdhesiolysisStatus unknownNCT04972032Not applicable
- Breast Cancer Liquid Biopsy TrialStatus unknownNCT04962529
- Periodontal Treatment and Ischemic StrokeStatus unknownNCT04956211Not applicable
- The Value of Preoperative Diagnosis and Prognostic Prediction Based on Radiomics of Giant Cell Tumor of SpineCompletedNCT04952818
- Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic SyndromesTerminatedNCT04951778Phase 1
- SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's LymphomaStatus unknownNCT04948788Phase 2
- CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell MalignanciesStatus unknownNCT04943016Phase 1
- SNP-based Prediction of Recurrence Risk in Kidney Stone PatientsStatus unknownNCT04937192
- A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)Status unknownNCT04933825Not applicable
- Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in IranCompletedNCT04928313
- Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisActive, not recruitingNCT04926818Phase 3
- Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)CompletedNCT04926285Phase 1
- Ingrown Toenails : Surgery Only Versus Surgery + Chemical Cauterization With TCAStatus unknownNCT04921540Not applicable
- Effect of Postoperative Additive Systemic Steroids in CRSwNPCompletedNCT04915456Phase 4
- How the Precise Habitats Can Predict the IDH Mutation Status and Prognosis of the Patients With High-grade GliomasStatus unknownNCT04908267
- A Drug-drug Interaction Study of Avapritinib and MidazolamCompletedNCT04908176Phase 1
- Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDSCompletedNCT04901416Phase 1
- Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple MyelomaTerminatedNCT04895410Phase 1
- Post-healing Follow-up Study in People With Remission of a Diabetic Foot UlcerCompletedNCT04892771
- Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsTerminatedNCT04892043Phase 1
- Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLTerminatedNCT04887259Phase 1
- Feasibility of a Novel Process-based Treatment for Patients With PsychosisCompletedNCT04874974Not applicable
- Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationCompletedNCT04872621
- A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical CancerCompletedNCT04868708Phase 2
- A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckCompletedNCT04868162Phase 2
- A Study to Evaluate the Tolerability, Safety, Pharmacokinetics of HEC89736 in Patients With Relapsed or Refractory B-cell Hematologic MalignanciesTerminatedNCT04865458Phase 1
- Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral CenterActive, not recruitingNCT04864626
- Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple MyelomaWithdrawnNCT04864522Phase 1/2
- A Study of HSK29116 in Adults With Relapsed/Refractory B-cell MalignanciesStatus unknownNCT04861779Phase 1
- NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.TerminatedNCT04861181Phase 4
- A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area LymphomaStatus unknownNCT04860674Phase 2
- A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT04860466Phase 1
- A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionStatus unknownNCT04856761
- A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.CompletedNCT04855929Phase 1
- Postoperative VEGF and Recurrence After Colon Cancer SurgeryStatus unknownNCT04851054
- Desarda Repair Compared to Lichtenstein Repair for the Treatment of Inguinal HerniasCompletedNCT04850131Not applicable
- Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)Active, not recruitingNCT04847739Phase 2
- Clinical Effectiveness of Bonded Versus Vacuum-formed RetainersCompletedNCT04847323Not applicable
- RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid MalignanciesTerminatedNCT04844086Phase 1
- Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell LymphomaActive, not recruitingNCT04842877Phase 2
- Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AMLStatus unknownNCT04842370Phase 1
- Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum CancerWithdrawnNCT04826029Not applicable
- Ketamine IV Classic Protocol : Five Years Follow upCompletedNCT04824157
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT04815720Phase 1/2
- Lung Cancer Patients' Attitudes to a Second Course of RadiotherapyStatus unknownNCT04813068
- A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTerminatedNCT04808570Phase 1/2
- Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.TerminatedNCT04797702Phase 1/2
- To Evaluate Efficacy and Safety of Parsaclisib Plus Either Rituximab or Obinutuzumab in R/R Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) (CITADEL-302)WithdrawnNCT04796922Phase 3
- Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCLStatus unknownNCT04796857Phase 1/2
- Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1TerminatedNCT04795713Phase 1
- A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWithdrawnNCT04791228Phase 2
- Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary LesionsStatus unknownNCT04790747Phase 1/2
- Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT04789655Phase 1
- Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor RelapseWithdrawnNCT04784221Phase 2
- Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.Status unknownNCT04780438Early Phase 1
- A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA SignalingCompletedNCT04773782Phase 1/2
- Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLCStatus unknownNCT04768491
- The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple MyelomaStatus unknownNCT04762745Phase 1/2
- Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in MonotherapyActive, not recruitingNCT04758533Phase 1/2